Rising Biosciences (Rising Biosciences) Interest Expense : $ Mil (TTM As of . 20)

View and export this data going back to . Start your Free Trial

What is Rising Biosciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Rising Biosciences's interest expense for the three months ended in . 20 was $ 0.00 Mil. Rising Biosciences does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Rising Biosciences's Operating Income for the three months ended in . 20 was $ 0.00 Mil. Rising Biosciences's Interest Expense for the three months ended in . 20 was $ 0.00 Mil. Rising Biosciences did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Rising Biosciences Interest Expense Historical Data

The historical data trend for Rising Biosciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Interest Expense Chart

Rising Biosciences Annual Data

Trend

Interest Expense

Rising Biosciences Quarterly Data

Interest Expense

Rising Biosciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Rising Biosciences (GREY:RBII) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Rising Biosciences's Interest Expense for the three months ended in . 20 was $0.00 Mil. Its Operating Income for the three months ended in . 20 was $0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in . 20 was $0.00 Mil.

Rising Biosciences's Interest Coverage for the quarter that ended in . 20 is calculated as

Rising Biosciences had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Rising Biosciences (Rising Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

1180 Cleveland Road, Sandusky, OH, USA, 44870

Website

http://www.risingbiosciences.com

Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.